Compared with the NC ApoE4− subjects, the AD patients had significantly higher Cp, higher Elocal, and longer Lp, but lower Eglobal (Fig. 1, E–H) regardless of their ApoE4 status (P<0.05). The gene discussed is APOE; the disease is Alzheimer disease.